---
$id: https://graph.org.ai/products/commodity/51161533
$type: Product
source: UNSPSC
code: "51161533"
title: "Isbufylline"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Isbufylline

**UNSPSC Code**: 51161533
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C11H16N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9C8Z5F38D0, chemically known as 3,7-dihydro-1,3-dimethyl-7-(2-methylpropyl)-1h-purine-2,6-dione but generally known as isbufylline, which bears US NIH Compound Identifier 65681. European Medicines Agency schedules Isbufylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08308MIG. The term ISBUFYLLINE is an International Non-Proprietary Name. ISBUFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule isbufylline under HS 29395900 and SITC 54145. As of Q4 2014, ISBUFYLLINE remains the US FDA Preferred Term for this commodity. Isbufylline bears US NLM identifiers UMLS ID C0043937 and NCI Concept Code C65970. SMILES: CC(C)CN1C=NC2=C1C(=O)N(C(=O)N2C)C.

